Cibele Sabido-David

Cibele Sabido-David Ph.D. has a diverse work experience spanning several companies and roles. From July 2022 to the present, they have been working as the Head of Business Development at Zambon. Prior to this, they held various leadership positions at Zambon, including Head of Next Generation Pharma Assets, Strategic Operations from February 2020 to June 2022, and Head of Business Development CNS and Other Therapeutic Areas from February 2017 to January 2020. Before joining Zambon, Cibele worked at Newron Pharmaceuticals SpA as the Business Development Director from 2003 to 2011. Cibele also has experience as a Group and Project Leader at GlaxoSmithKline UK from 1997 to 2003. Cibele started their career in academia as a Postdoctoral Scientist at King's College London and later as a Visiting Postdoctoral Researcher at the University of Pennsylvania in 1996.

Cibele Sabido-David Ph.D. obtained a Bachelor of Science degree in Biotechnology from Imperial College London, spanning from 1988 to 1992. Cibele pursued their doctoral studies in Biophysics at King's College London, completing their Ph.D. from 1992 to 1997.